News for Optiscan Imaging Limited (OIL.AX)

Published at

May 27, 2025 8:52 AM

by themarketherald.com.au

mixed

mixed

ASX Market Close: Index climbs on positive US futures | May 27, 2025

The ASX200 closed up 0.56% at 8,407 points. IT was the leading…

WZR.AX OIL.AX ORG.AX DXN.AX

Read more →
Published at

Feb 3, 2025 12:09 AM

by themarketherald.com.au

positive

positive

Optiscan starts German trial to test imaging capability on gastrointestinal tract

Optiscan Imaging Ltd has begun a pre-clinical trial in Mainz, Germany, which involves completion of a prototype to collect images

OIL.AX

Read more →
Published at

Jul 29, 2024 4:31 AM

by smallcaps.com.au

neutral

neutral

Optiscan Imaging completes beta phase testing of cloud-based telepathology platform

Commercial-stage medical technology company Optiscan Imaging (ASX: OIL) has completed beta phase testing of its cloud-based telepathology platform

OIL.AX

Read more →
Published at

Jun 28, 2024 8:15 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps and IPO Weekly Wrap: Another decent week for the techies… shame about the rest

Aussie markets have somehow pulled of a miracle gain despite two horror sessions this week.

VTMXF VN8.AX VML.AX TD1.AX RWD.AX ROG.AX RDS.AX RCL.AX QXR.AX MYR.AX MTH.AX MNB.AX MLM.AX KOR.AX IRI.AX IMR.AX HTG.AX HT8.AX HLX.AX EZL.AX DRX.AX CLZ.AX BYH.AX BUR.AX BSX.AX BMO.AX ACW.AX SIS.AX SFX.AX RNE.AX PPY.AX MSG.AX MRQ.AX MOZ.AX MMM.AX MCL.AX K2F.AX GMN.AX FHS.AX ERL.AX EOFBF EOF.AX ENR.AX EDE.AX DOU.AX CLU.AX BEL.AX BBN.AX AUK.AX AQI.AX AD1.AX AAJ.AX A3D.AX 3DP.AX TTM.AX STX.AX SRY.AX OIL.AX MRL.AX KRR.AX KKO.AX JAT.AX ICR.AX GLH.AX FTC.AX CMD.AX AMD.AX AL3.AX

Read more →
Published at

Jun 4, 2024 8:50 AM

by themarketherald.com.au

mixed

mixed

Daily Market ASX Close: the ASX closes red as Energy drags down market | June 4, 2024

The ASX200 closed the day in the red, down 0.3%. It was a rough day for the Energy sector, falling 1.6%, with Materials down 0.9%. The Financial and Staples sectors were the only ones that pushed into the green, both up around 0.2%.

LOV.AX 360.AX OIL.AX AGC.AX

Read more →
Published at

Jun 4, 2024 3:18 AM

by smallcaps.com.au

positive

positive

Optiscan reveals InVue real-time imaging device for precision surgery

Optiscan Imaging (ASX: OIL) has revealed the InVue microscopic medical imaging device, designed to benefit the surgical market by providing real-time

OIL.AX

Read more →
Published at

May 13, 2024 4:02 PM

by financialpost.com

positive

positive

Optiscan Signs Know-How Agreement with Mayo Clinic

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

OIL.AX

Read more →
Published at

May 13, 2024 8:51 AM

by themarketherald.com.au

mixed

mixed

Market Close: ASX slips over the finest of lines turning red into green

The ASX200 closed 0.2 of a per cent down. Energy slipped around a per cent, while consumer discretionary and healthcare grew around 0.5%.

LLESY LLESF LLC.AX SXL.AX STO.AX OIL.AX RMS.AX

Read more →
Published at

May 13, 2024 6:10 AM

by themarketherald.com.au

positive

positive

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system

OIL.AX

Read more →
Published at

Feb 13, 2024 11:34 PM

by themarketherald.com.au

positive

positive

Market Open: ASX200 braces for red Wednesday as US inflation comes in hotter than expected

US inflation data came in higher than tipped, rattling the markets over there, with the ripple effect expected to reach the ASX200 today.

OIL.AX NZO.AX HZN.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 16, 2023 6:28 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: Because sometimes you just know when enough is enough

A big day on the ASX today, after the benchmark knocked off at +0.8%, and AQC CEO David Conry knocked off around lunchtime, apparently for good.

TSL.AX SUL.AX SPT.AX SIX.AX MTH.AX MP1.AX KZA.AX GTG.AX BBN.AX AQC.AX 360.AX WCN.AX T3D.AX SCT.AX N1H.AX MEB.AX MDBIF KRM.AX INR.AX GSCCF WWI.AX VPR.AX TD1.AX SRI.AX RVS.AX RDN.AX OIL.AX KEY.AX IBG.AX GLV.AX EMT.AX BWXXF BWX.AX BC8.AX ANL.AX AMS.AX AAJ.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 24, 2022 8:20 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

Guy's got some gold that's 'bigger than Texas', how to protect your shares from a 'platform' collapse, and why the 'tech-led' recession is actually not.

TZLTF TZL.AX TER.AX SYA.AX RBR.AX RAG.AX POD.AX PLL.AX PG1.AX PEN.AX NNG.AX MMM.AX MLYSF M24.AX KNM.AX JAY.AX ICL.AX HRN.AX EZL.AX EWC.AX CRR.AX BML.AX AOU.AX AFL.AX TSL.AX OIL.AX MTH.AX MEB.AX MDBIF MCM.AX LSR.AX KFE.AX IVZ.AX IRI.AX GRV.AX GLV.AX ERL.AX BXN.AX BITRF BIT.AX AX8.AX AVW.AX AUK.AX 99L.AX WSR.AX AUN.AX AQX.AX

Read more →
Published at

Nov 24, 2022 6:39 AM

by stockhead.com.au

mixed

mixed

Closing Bell: RBA tries (and fails) to dampen investor enthusiasm as ASX edges to 6mth high

ASX 200 ends flat today, small cap index falls 0.44% but 7 out of 11 sectors were in the green.

TZLTF TZL.AX TER.AX RBR.AX RAG.AX POD.AX PG1.AX MGV.AX M24.AX LSR.AX JAY.AX ICL.AX HRN.AX EZL.AX EWC.AX CRR.AX AX8.AX XRO.AX WTC.AX TSL.AX STO.AX STG.AX OIL.AX MTH.AX MEB.AX MDBIF MCM.AX KNM.AX KFE.AX IVZ.AX IRI.AX GRV.AX GLV.AX BXN.AX BML.AX BITRF BIT.AX AVW.AX AUK.AX AOU.AX AFL.AX 99L.AX ERS ERL.AX AQX.AX

Read more →
Published at

Nov 23, 2022 7:50 PM

by stockhead.com.au

mixed

mixed

How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors but could it also do with better PR?

VTG.AX NEU.AX MXC.AX KZA.AX CSL.AX COH.AX BWXXF BWX.AX AT1.AX ADR.AX ADO.AX ZNO.AX ZLD.AX UBI.AX TD1.AX SHL.AX RSH.AX RHT.AX RAC.AX PNV.AX PBP.AX OVN.AX OSX.AX OSL.AX OCC.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX ICS.AX ICR.AX EYE.AX CPH.AX CMP.AX CALZF BXN.AX AMDHF 1ST.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDR.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX IDT.AX HCT.AX GTG.AX GSS.AX GLH.AX FDMDF DXB.AX DVL.AX CYP.AX CKDXF CGS.AX CAN.AX CAJ.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 4, 2022 4:51 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO Wrap: The Fed’s scorecard in War on Inflation; WA1 only up a mediocre 122% this week

S&P/ASX Emerging Companies (XEC) index was up by 0.4% on Friday, but down 1% for the five sessions to, 2.30pm today in Sydney.

STG.AX SES.AX RDY.AX RDBBY RDBBF RBX.AX RBL.AX QXR.AX OMHLF OMH.AX NTO.AX MAY.AX LGP.AX KLL.AX IVZ.AX GME.AX FEX.AX EML.AX DRE.AX CYM.AX CXO.AX CXL.AX BUENF BLU.AX BAT.AX AUT.AX AMI.AX 3PL.AX WSP.AX WHSPF WCG.AX VRC.AX VR1.AX UBNDA.AX UBN.AX TRS.AX TPW.AX SPQ.AX SFG.AX SDV.AX OIL.AX MRL.AX MMM.AX MMI.AX LTR.AX LPD.AX LIN.AX HZRGF HZR.AX FGR.AX EEG.AX DTZ.AX CSX.AX CBR.AX AVA.AX ASP.AX ALK.AX AIS.AX TI1.AX STK.AX SPZ.AX SHM.AX NVA.AX NOXOF NOX.AX MCM.AX MCL.AX LRK.AX IOD.AX FLN.AX EYE.AX DRX.AX CVW.AX CGF.AX BNL.AX

Read more →